Award
NIH Reporter #1R43AI192098-01A1
Discovery of Group A Streptococcus antigens for development of broadly effective vaccine candidates to prevent non-invasive and invasive disease and emergence of antimicrobial resistance
Recipient
IMMPORT THERAPEUTICS, INC.
Award Amount
$300,000.00
Ceiling
$300,000.00
Awarded
August 26, 2026
Identifier
1R43AI192098-01A1
Award for research and development of vaccine candidates targeting Group A Streptococcus to prevent disease and antimicrobial resistance, involving antigen discovery and antibody assay development.
Description
Development and testing of a S. pyogenes panproteome microarray, development of antigen-specific functional assays, and longitudinal study of antibody responses focused on vaccine development for Streptococcus pyogenes with collaboration with multiple research institutions and emphasis on novel antigen discovery and functional antibody assays.